Showing results (41-50 of 74) with videos related to
Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patientsJ Cassidy, L Saltz, C Twelves, et al.Cancer|October 15, 1994
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancerD P Kelsen, L Saltz, A M Cohen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Advanced hepatocellular carcinoma: which staging systems best predict prognosis?Fidel-David Huitzil-Melendez, Marinela Capanu, Eileen M O'Reilly, et al.Cancer|November 1, 1996
A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescueG K Schwartz, K Christman, L Saltz, et al.Journal of the National Cancer Institute|September 15, 1993
Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factorL Saltz, M Sirott, C Young, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinomaG K Schwartz, D Ilson, L Saltz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancerD Kelsen, O T Atiq, L Saltz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2007
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinomaA Duffy, J Kortmansky, G K Schwartz, et al.British Journal of Cancer|June 16, 2011
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsJ Cassidy, S Clarke, E Díaz-Rubio, et al.Cancer|November 15, 1994
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistanceL Saltz, B Murphy, N Kemeny, et al.Pageof 8